Mettu, N. B., Uronis, J. M., Osada, T., Lu, M., Osada, K., Mook, R., … Hsu, S. D. (2014). Functional genomic screens and identification of signaling pathways in oxaliplatin-resistance in colorectal cancer. In Journal of Clinical Oncology (Vol. 32, pp. 3611–3611). American Society of Clinical Oncology (ASCO). https://doi.org/10.1200/jco.2014.32.15_suppl.3611

Mettu, Niharika B., Joshua M. Uronis, Takuya Osada, Min Lu, Koya Osada, Robert Mook, Wei Chen, et al. “Functional genomic screens and identification of signaling pathways in oxaliplatin-resistance in colorectal cancer.” In Journal of Clinical Oncology, 32:3611–3611. American Society of Clinical Oncology (ASCO), 2014. https://doi.org/10.1200/jco.2014.32.15_suppl.3611.

Mettu NB, Uronis JM, Osada T, Lu M, Osada K, Mook R, et al. Functional genomic screens and identification of signaling pathways in oxaliplatin-resistance in colorectal cancer. In: Journal of Clinical Oncology. American Society of Clinical Oncology (ASCO); 2014. p. 3611–3611.

Mettu, Niharika B., et al. “Functional genomic screens and identification of signaling pathways in oxaliplatin-resistance in colorectal cancer.” Journal of Clinical Oncology, vol. 32, no. 15_suppl, American Society of Clinical Oncology (ASCO), 2014, pp. 3611–3611. Crossref, doi:10.1200/jco.2014.32.15_suppl.3611.

Mettu NB, Uronis JM, Osada T, Lu M, Osada K, Mook R, Chen W, Morse M, Lyerly HK, Wood K, Hsu SD. Functional genomic screens and identification of signaling pathways in oxaliplatin-resistance in colorectal cancer. Journal of Clinical Oncology. American Society of Clinical Oncology (ASCO); 2014. p. 3611–3611.